Innoviva (INVA) Tops Q3 EPS by 71c

Innoviva (NASDAQ: INVA) reported Q3 EPS of $0.98, $0.71 better than the analyst estimate of $0.27. Revenue for the quarter came in at $67.26 million versus the consensus estimate of $75.66 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Bernstein SocGen on UnitedHealth Group (UNH): 'Expecting a strong 2Q driven by MA and potential for guidance raise'
• AeroVironment posts record quarterly revenue, issues FY2027 outlook